Follow the Money to Medical Devices & Diagnostics
Spotlight on Tear Film Innovations, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities.

Tear Film Innovations is a private US company that develops medical devices for the treatment of evaporative dry eye and related syndromes. It raised $9 million in the completion of a venture capital investment as reported in the PharmSource Lead Sheet on November 9, 2017.

Corporate Highlights

  • Tear Film Innovations was founded in 2014
  • Corporate Headquarters: San Diego, CA

Sourcing Opportunities

  • Tear Film Innovations plans to use the proceeds to support regulatory approvals and commercialization efforts for its iLux system:

Device: iLux systemTM
Development Phase: Pivotal studies
Medical Specialty: Ophthalmology
Purpose: Device – Therapeutic/Interventional
Type: Instrument/Tool
Description: A device that is comprised of a handheld instrument and a disposable tip to identify blocked meibomian glands and then applies a gentle, painless treatment.

Medical Device & Diagnostics Pipeline1

Product Candidate Indication Medical Specialty Purpose Type Status
iLux system Minimal ophthalmological procedures Ophthalmology Device – Therapeutic/
Interventional
Instrument/Tool Pilot studies

1Source: PharmSource Lead Sheet

Contact Information

Tear Film Innovations, Inc. Key Officers
12625 High Bluff Drive, Suite 107 Rob Thornhill, President & CEO
San Diego, CA 92130 USA John Slate, VP, R&D
Web: http://www.tearfilm.com/

 

Related posts:
Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on Cambridge Medical Robotics Ltd.
Follow the Money to Medical Devices & Diagnostics
Spotlight on SetPoint Medical Corp.

Follow the Money to Medical Device & Diagnostic Opportunities – Spotlight on SEBACIA, Inc.

Scotty is a Research Analyst at PharmSource. He holds a BS degree in Biology from George Mason University and an MPH degree from Eastern Virginia Medical School. He’s experienced in data collection, analysis and management, and has done laboratory analysis and safety program development.

More posts by Scotty Chung-Siu